Effect of flurazepam, pentobarbital, and caffeine on arousal threshold.
After laboratory and procedure adaptation, 6 normal subjects were randomly administered 30 mg flurazepam (twice), 100 mg pentobarbital (twice), 400 mg caffeine (once), and placebo (twice) on nonconsecutive nights. On each night subjects were aroused from standard segments of stage 2 sleep five to eight times with an ascending series of 1,000 Hz tones produced by an audiometer. Arousal threshold and awake threshold after each arousal were measured. Both thresholds were increased by flurazepam and pentobarbital and decreased by caffeine. All of the drugs appeared to modify arousal threshold in a time course fashion such that extreme effects were found during the first half of the night. However, the modifications of waking threshold by caffeine and flurazepam continued throughout the sleep period. The method may be a means of measuring the behavioral time course of drug activity during the sleep period.
D000328:Adult; D001143:Arousal / Q000187:drug effects*; D001309:Auditory Threshold / Q000187:drug effects; D002110:Caffeine / Q000494:pharmacology*; D005479:Flurazepam / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010424:Pentobarbital / Q000494:pharmacology*; D012894:Sleep Stages / Q000187:drug effects*; D014851:Wakefulness / Q000187:drug effects
D002110:Caffeine; D010424:Pentobarbital; D005479:Flurazepam